[Autor: helmut.dollfuss@meduniwien.ac.at]

Der Verlag Bentham bietet bis zum 25. Mai 2009 einen Testzugang zu 111 e-Journals.

=> Link zur Zeitschriftenplattform Bentham

Die folgenden Titel stehen ab sofort im Computernetz der Med. Universität Wien zur Verfügung:

1. Advances in Organic Synthesis
2. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry – Anti-Cancer Agents)
3. Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry – Anti-Infective Agents)
4. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry – Anti-Inflammatory and Anti-Allergy Agents)
5. Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry – Cardiovascular & Hematological Agents)
6. Cardiovascular & Hematological Disorders-Drug Targets (Formerly Current Drug Targets – Cardiovascular & Hematological Disorders)
7. Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry – Central Nervous System Agents)
8. CNS & Neurological Disorders – Drug Targets (Formerly Current Drug Targets – CNS & Neurological Disorders)
9. Combinatorial Chemistry & High Throughput Screening
10. Current Aging Science
11. Current Alzheimer Research
12. Current Analytical Chemistry
13. Current Bioactive Compounds
14. Current Bioinformatics
15. Current Cancer Drug Targets
16. Current Cancer Therapy Reviews
17. Current Cardiology Reviews
18. Current Chemical Biology
19. Current Clinical Pharmacology
20. Current Computer Aided-Drug Design
21. Current Diabetes Reviews
22. Current Drug Abuse Reviews
23. Current Drug Delivery
24. Current Drug Discovery Technologies
25. Current Drug Metabolism
26. Current Drug Safety
27. Current Drug Target -Cardiovascular & Hematological Disorders
28. Current Drug Target -CNS & Neurological Disorders
29. Current Drug Target -Endocrine, Metabolic & Immune Disorders
30. Current Drug Target -Infectious Disorders
31. Current Drug Target -Inflammation & Allergy
32. Current Drug Targets
33. Current Drug Therapy
34. Current Enzyme Inhibition
35. Current Gene Therapy
36. Current Genomics
37. Current HIV Research
38. Current Hypertension Reviews
39. Current Immunology Reviews
40. Current Medical Imaging Reviews
41. Current Medicinal Chemistry
42. Current Medicinal Chemistry -Anti-Infective Agents
43. Current Medicinal Chemistry Anti-Inflammatory & Anti-Allergy Agents
44. Current Medicinal Chemistry-Anti-Cancer Agents
45. Current Medicinal Chemistry-Cardiovascular & Hematological Agents
46. Current Medicinal Chemistry-Central Nervous System Agents
47. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents
48. Current Molecular Medicine
49. Current Molecular Pharmacology
50. Current Nanoscience
51. Current Neuropharmacology
52. Current Neurovascular Research
53. Current Nutrition & Food Science
54. Current Organic Chemistry
55. Current Organic Synthesis
56. Current Pediatric Reviews
57. Current Pharmaceutical Analysis
58. Current Pharmaceutical Biotechnology
59. Current Pharmaceutical Design
60. Current Pharmacogenomics
61. Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
62. Current Protein & Peptide Science
63. Current Proteomics
64. Current Psychiatry Reviews
65. Current Radiopharmaceuticals
66. Current Respiratory Medicine Reviews
67. Current Rheumatology Reviews
68. Current Signal Transduction Therapy
69. Current Stem Cell Research & Therapy
70. Current Topics in Medicinal Chemistry
71. Current Vascular Pharmacology
72. Current Women`s Health Reviews
73. Drug Design Reviews – Online (Discontinued)
74. Drug Metabolism Letters
75. Endocrine‚ Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets – Immune‚ Endocrine & Metabolic Disorders)
76. Frontiers in Drug Design & Discovery
77. Frontiers in Drug Design & Discovery: Structure-Based Drug Design in the 21st Century
78. Frontiers in Medicinal Chemistry
79. Frontiers in Natural Product Chemistry
80. Frontiers in Organic Chemistry
81. Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry – Immunology‚ Endocrine and Metabolic Agents)
82. Infectious Disorders – Drug Targets (Formerly Current Drug Targets – Infectious Disorders)
83. Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets – Inflammation & Allergy)
84. Letters in Drug Design & Discovery
85. Letters in Organic Chemistry
86. Medicinal Chemistry
87. Medicinal Chemistry Reviews – Online (Discontinued)
88. Mini-Reviews in Medicinal Chemistry
89. Mini-Reviews in Organic Chemistry
90. Protein and Peptide Letters
91. Recent Patents on Anti-Cancer Drug Discovery
92. Recent Patents on Anti-Infective Drug Discovery
93. Recent Patents on Biomedical Engineering
94. Recent Patents on Biotechnology
95. Recent Patents on Cardiovascular Drug Discovery
96. Recent Patents on Chemical Engineering
97. Recent Patents on CNS Drug Discovery
98. Recent Patents on Computer Science
99. Recent Patents on DNA & Gene Sequences
100. Recent Patents on Drug Delivery & Formulation
101. Recent Patents on Electrical Engineering
102. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
103. Recent Patents on Engineering
104. Recent Patents on Inflammation & Allergy Drug Discovery
105. Recent Patents on Materials Science
106. Recent Patents on Mechanical Engineering
107. Recent Patents on Nanotechnology
108. Reviews on Recent Clinical Trials(Online)
109. The Pharmaceutical Scientist Guide to Solution Kinetic Models : Mathematical Description and Applications
110. Vascular Disease Prevention
111. What`s Doing? A Tribute to Professor Murray Goodman

[Autor: helmut.dollfuss@meduniwien.ac.at]

SciBX: Science–Business eXchange is a groundbreaking weekly publication that provides a timely, concise and understandable analysis of the scientific content and commercial potential of the most important translational research papers from across the life science literature. The editorial team at SciBX mines thousands of articles across the literature each week and distill the flood of information down to the 25 most important developments. And by reporting the industry viewpoint on the key papers, SciBX provides a unique and essential scientific and commercial perspective on today’s breakthrough science.

Die Zeitschrift SciBX steht im Testzugang bis Ende April 2009 im Computernetz der Medizinischen Universität Wien zur Verfügung.

=> Link zu SciBX

[Autor: Helmut.Dollfuss@meduniwien.ac.at]

SciBX: Science–Business eXchange is a groundbreaking weekly publication that provides a timely, concise and understandable analysis of the scientific content and commercial potential of the most important translational research papers from across the life science literature. The editorial team at SciBX mines thousands of articles across the literature each week and distill the flood of information down to the 25 most important developments. And by reporting the industry viewpoint on the key papers, SciBX provides a unique and essential scientific and commercial perspective on today’s breakthrough science.

Die Zeitschrift SciBX steht im Testzugang bis Ende März 2009 im Computernetz der Medizinischen Universität Wien zur Verfügung.

=> Link zu SciBX